GLP-1 receptor agonists were not associated with recurrence or progression in well differentiated thyroid cancer, supporting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results